Observational Study on Characteristics and Survival Correlates of Progressive Multifocal Leukoencephalopathy (PML) in Italy

计划入组 456 人 · 首次发布于 2024 年 9 月 13 日

Genetics of Progressive Multifocal Leukoencephalopathy and Acquired Immunodeficiency Syndrome

计划入组 450 人 · 首次发布于 2006 年 6 月 21 日

Longitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML Risk

计划入组 196 人 · 首次发布于 2015 年 5 月 12 日

Nogapendekin alfa inbakicept-pmln

PMD-028/PMD-029

PMC-404

PMV Pharmaceuticals

United States

ANIRBAN PAL

India

BEAT AML, LLC

United States

First European Real-World Analysis Validates ImmunoWELL JCV Test for PML Risk Assessment in Multiple Sclerosis Patients

Experimental Off-the-Shelf T Cell Therapy Achieves 56.8% Response Rate in Rare, Often Fatal Brain Infection

Apitegromab Shows Promise in Phase III Spinal Muscular Atrophy Trial, Scholar Rock Reports